Companies confirm that markers of weight loss and glycemic control are distinct in preliminary study, with multiple mechanisms identified that provide opportunities to guide indication extension
Sandwich, UK — 15 April 2026: International contract research organisation ChemPartner has officially opened its first European scientific hub at Discovery Park, Sandwich, Kent. The company works with the biopharmaceutical industry to efficiently and rapidly bring life-changing drugs to market.
Founded in Shanghai in 2002, ChemPartner has more than 2,000 employees globally, most of whom are based in Asia. The company currently has seven UK employees, many of whom work hybrid, and is actively recruiting for a Senior Scientist to be based at Discovery Park.
Over two days, this event will cover a range of topics spanning the fundamental basis and regulation of stress responses and protein folding in the cell, to the relevance of these processes in health, disease, and ageing.
Abstract deadline: 1 May 2026
Registration deadline: 10 July 2026
Registration Fee: Student/Postdoc £45 | Group Leader/ Industry participant £75
The registration fee includes lunch and dinner on July 20th, food and drinks during networking/poster sessions, and lunch on July 21st. Accommodation is not included.
In this webinar, Dr Emma Jones explores how human iPSC-derived CNS models are used to study neuroinflammation across 2D and 3D systems, highlighting microglia-driven responses, tri-culture integration, and functional readouts in bioprinted 3D environments.
Key learning points
- How 2D human microglia models are characterised using functional readouts, imaging and single-cell analysis
- What changes when transitioning from 2D to 3D CNS models
- How microglia integrate into 3D tri-culture systems
Life Science Editors is hosting a Manuscript Assessment Masterclass: a two-hour, hands-on coaching session led by Dr. Heather Van Epps (former Editor-in-Chief, The Lancet Rheumatology and PLOS Medicine) and Dr. Carol Featherstone (founding editor, Trends in Cell Biology).
The session is designed to give participants the tools to assess manuscript submissions with fairness, insight, and editorial precision, exactly the skills tested in the editorial candidate assessments used by major journals.
ELRIG Announces Inaugural US Drug Discovery Conference
What if the work you did every day could impact the lives of people you know? Or all of humanity?
At Illumina, we are expanding access to genomic technology to realize health equity for billions of people around the world. Our efforts enable life-changing discoveries that are transforming human health through the early detection and diagnosis of diseases and new treatment options for patients.
An exciting opportunity has arisen for a Research Assistant to support the Wheat Transformation and Gene Editing (WTGE) facility at the John Innes Centre, working on cutting-edge precision breeding technology.
The role
This exciting role will contribute to wheat transformation for both target gene overexpression and CRISPR/Cas9-mediated gene editing to generate targeted mutations. The post holder will also be part of work at the frontier of gene editing and transformation technologies, supporting the John Innes Centre’s Precision Breeding Hub.
Do you want to help us improve human health and understand life on Earth? Make your mark by shaping the future to enable or deliver life-changing science to solve some of humanity’s greatest challenges.